Skip to main content

Abstract 4256: Long-read RNA sequencing and immunopeptidomics reveal transcriptomic aberrationneoantigens as targets for T cell immunotherapy in diffuse glioma

Publication ,  Conference
Zhang, K; Benz, M; Hotchkiss, KM; Lin, L; Quackenbush, S; Payros, AE; Pieterse, M; Kloosterman, W; Kneppers, J; Khasraw, M
Published in: Cancer Research
April 3, 2026

Duke Scholars

Published In

Cancer Research

DOI

EISSN

1538-7445

ISSN

0008-5472

Publication Date

April 3, 2026

Volume

86

Issue

7_Supplement

Start / End Page

4256 / 4256

Publisher

American Association for Cancer Research (AACR)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3101 Biochemistry and cell biology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Zhang, K., Benz, M., Hotchkiss, K. M., Lin, L., Quackenbush, S., Payros, A. E., … Khasraw, M. (2026). Abstract 4256: Long-read RNA sequencing and immunopeptidomics reveal transcriptomic aberrationneoantigens as targets for T cell immunotherapy in diffuse glioma. In Cancer Research (Vol. 86, pp. 4256–4256). American Association for Cancer Research (AACR). https://doi.org/10.1158/1538-7445.am2026-4256
Zhang, Kenan, Megan Benz, Kelly M. Hotchkiss, Lin Lin, Sarah Quackenbush, Aroa Elortza Payros, Mark Pieterse, Wigard Kloosterman, Jeroen Kneppers, and Mustafa Khasraw. “Abstract 4256: Long-read RNA sequencing and immunopeptidomics reveal transcriptomic aberrationneoantigens as targets for T cell immunotherapy in diffuse glioma.” In Cancer Research, 86:4256–4256. American Association for Cancer Research (AACR), 2026. https://doi.org/10.1158/1538-7445.am2026-4256.
Zhang K, Benz M, Hotchkiss KM, Lin L, Quackenbush S, Payros AE, et al. Abstract 4256: Long-read RNA sequencing and immunopeptidomics reveal transcriptomic aberrationneoantigens as targets for T cell immunotherapy in diffuse glioma. In: Cancer Research. American Association for Cancer Research (AACR); 2026. p. 4256–4256.
Zhang, Kenan, et al. “Abstract 4256: Long-read RNA sequencing and immunopeptidomics reveal transcriptomic aberrationneoantigens as targets for T cell immunotherapy in diffuse glioma.” Cancer Research, vol. 86, no. 7_Supplement, American Association for Cancer Research (AACR), 2026, pp. 4256–4256. Crossref, doi:10.1158/1538-7445.am2026-4256.
Zhang K, Benz M, Hotchkiss KM, Lin L, Quackenbush S, Payros AE, Pieterse M, Kloosterman W, Kneppers J, Khasraw M. Abstract 4256: Long-read RNA sequencing and immunopeptidomics reveal transcriptomic aberrationneoantigens as targets for T cell immunotherapy in diffuse glioma. Cancer Research. American Association for Cancer Research (AACR); 2026. p. 4256–4256.

Published In

Cancer Research

DOI

EISSN

1538-7445

ISSN

0008-5472

Publication Date

April 3, 2026

Volume

86

Issue

7_Supplement

Start / End Page

4256 / 4256

Publisher

American Association for Cancer Research (AACR)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3101 Biochemistry and cell biology